Cybin (HELP) Other Working Capital Changes (2024)
Cybin (HELP) posted quarterly Other Working Capital Changes of -$7.4 million for Q1 2026, down 59281.33% year-on-year from N/an in Q1 2025, and down 3093.55% on a QoQ basis from $248000.0 in Q4 2025.
Cybin (HELP) Other Working Capital Changes (2024) Analysis & Trends
Cybin (HELP) has reported Other Working Capital Changes for 1 consecutive years, with -$81606.8 the latest figure, recorded in Q4 2024.
- Quarterly Other Working Capital Changes fell 59281.33% year-over-year to -$7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.8 million (down 1225.55% YoY) and the FY2026 annual result came in at -$6.8 million, up 48.61% from the prior year.
- Other Working Capital Changes eased to -$7.4 million in Q1 2026 per HELP's latest filing, from $248000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for HELP reached as high as $630731.6 in Q1 2023 and fell as low as -$7.4 million in Q1 2026.
- A 5-year average of -$421458.2 and a median of $12544.5 in 2025 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes soared 962.08% — and 2026, when it sank 59281.33%.
- Year by year, Other Working Capital Changes stood at $67040.0 in 2022, then plunged by 404.6% to -$204200.9 in 2023, then sank by 363.44% to -$946352.6 in 2024, then surged by 126.21% to $248000.0 in 2025, then sank by 3093.55% to -$7.4 million in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$81606.8, -$65974.8, and -$62878.1 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -81,606.80 |
| Dec 31, 2024 | -81,606.80 |
| Dec 31, 2024 | -81,606.80 |
| Sep 30, 2024 | -65,974.81 |
| Sep 30, 2024 | -65,974.81 |
| Sep 30, 2024 | -65,974.81 |
| Jun 30, 2024 | -62,878.09 |
| Jun 30, 2024 | -62,878.09 |
| Jun 30, 2024 | -62,878.09 |